161 related articles for article (PubMed ID: 27056048)
1. Inhibition of fibroblast growth factor receptor 3-dependent lung adenocarcinoma with a human monoclonal antibody.
Yin Y; Ren X; Smith C; Guo Q; Malabunga M; Guernah I; Zhang Y; Shen J; Sun H; Chehab N; Loizos N; Ludwig DL; Ornitz DM
Dis Model Mech; 2016 May; 9(5):563-71. PubMed ID: 27056048
[TBL] [Abstract][Full Text] [Related]
2. Rapid induction of lung adenocarcinoma by fibroblast growth factor 9 signaling through FGF receptor 3.
Yin Y; Betsuyaku T; Garbow JR; Miao J; Govindan R; Ornitz DM
Cancer Res; 2013 Sep; 73(18):5730-41. PubMed ID: 23867472
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the cell of origin and propagation potential of the fibroblast growth factor 9-induced mouse model of lung adenocarcinoma.
Arai D; Hegab AE; Soejima K; Kuroda A; Ishioka K; Yasuda H; Naoki K; Shizuko K; Hamamoto J; Yin Y; Ornitz DM; Betsuyaku T
J Pathol; 2015 Mar; 235(4):593-605. PubMed ID: 25413587
[TBL] [Abstract][Full Text] [Related]
4. Effect of FGF/FGFR pathway blocking on lung adenocarcinoma and its cancer-associated fibroblasts.
Hegab AE; Ozaki M; Kameyama N; Gao J; Kagawa S; Yasuda H; Soejima K; Yin Y; Guzy RD; Nakamura Y; Ornitz DM; Betsuyaku T
J Pathol; 2019 Oct; 249(2):193-205. PubMed ID: 31090071
[TBL] [Abstract][Full Text] [Related]
5. Targeting the extracellular domain of fibroblast growth factor receptor 3 with human single-chain Fv antibodies inhibits bladder carcinoma cell line proliferation.
Martínez-Torrecuadrada J; Cifuentes G; López-Serra P; Saenz P; Martínez A; Casal JI
Clin Cancer Res; 2005 Sep; 11(17):6280-90. PubMed ID: 16144932
[TBL] [Abstract][Full Text] [Related]
6. Drug-sensitive FGFR3 mutations in lung adenocarcinoma.
Chandrani P; Prabhash K; Prasad R; Sethunath V; Ranjan M; Iyer P; Aich J; Dhamne H; Iyer DN; Upadhyay P; Mohanty B; Chandna P; Kumar R; Joshi A; Noronha V; Patil V; Ramaswamy A; Karpe A; Thorat R; Chaudhari P; Ingle A; Choughule A; Dutt A
Ann Oncol; 2017 Mar; 28(3):597-603. PubMed ID: 27998968
[TBL] [Abstract][Full Text] [Related]
7. Tumor associated macrophages support the growth of FGF9-induced lung adenocarcinoma by multiple mechanisms.
Hegab AE; Ozaki M; Kagawa S; Hamamoto J; Yasuda H; Naoki K; Soejima K; Yin Y; Kinoshita T; Yaguchi T; Kawakami Y; Ornitz DM; Betsuyaku T
Lung Cancer; 2018 May; 119():25-35. PubMed ID: 29656749
[TBL] [Abstract][Full Text] [Related]
8. Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice.
Qing J; Du X; Chen Y; Chan P; Li H; Wu P; Marsters S; Stawicki S; Tien J; Totpal K; Ross S; Stinson S; Dornan D; French D; Wang QR; Stephan JP; Wu Y; Wiesmann C; Ashkenazi A
J Clin Invest; 2009 May; 119(5):1216-29. PubMed ID: 19381019
[TBL] [Abstract][Full Text] [Related]
9. Generation of monoclonal antibody targeting fibroblast growth factor receptor 3.
Gorbenko O; Ovcharenko G; Klymenko T; Zhyvoloup O; Gaman N; Volkova D; Gout I; Filonenko V
Hybridoma (Larchmt); 2009 Aug; 28(4):295-300. PubMed ID: 19663703
[TBL] [Abstract][Full Text] [Related]
10. Anti-Cancer Effect of Cordycepin on FGF9-Induced Testicular Tumorigenesis.
Chang MM; Hong SY; Yang SH; Wu CC; Wang CY; Huang BM
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33172093
[TBL] [Abstract][Full Text] [Related]
11. Expression of fibroblast growth factor 9 is associated with poor prognosis in patients with resected non-small cell lung cancer.
Ohgino K; Soejima K; Yasuda H; Hayashi Y; Hamamoto J; Naoki K; Arai D; Ishioka K; Sato T; Terai H; Ikemura S; Yoda S; Tani T; Kuroda A; Betsuyaku T
Lung Cancer; 2014 Jan; 83(1):90-6. PubMed ID: 24239165
[TBL] [Abstract][Full Text] [Related]
12. miR-24-3p/FGFR3 Signaling as a Novel Axis Is Involved in Epithelial-Mesenchymal Transition and Regulates Lung Adenocarcinoma Progression.
Jing P; Zhao N; Xie N; Ye M; Zhang Y; Zhang Z; Li M; Lai X; Zhang J; Gu Z
J Immunol Res; 2018; 2018():2834109. PubMed ID: 29850625
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effect of anti CEACAM6 monoclonal antibody against lung adenocarcinoma by enhancing anoikis sensitivity.
Hong KP; Shin MH; Yoon S; Ji GY; Moon YR; Lee OJ; Choi SY; Lee YM; Koo JH; Lee HC; Lee GK; Kim SR; Lee KH; Han HS; Choe KH; Lee KM; Hong JM; Kim SW; Yi JH; Ji HJ; Kim YB; Song HG
Biomaterials; 2015 Oct; 67():32-41. PubMed ID: 26204223
[TBL] [Abstract][Full Text] [Related]
14. Directionally specific paracrine communication mediated by epithelial FGF9 to stromal FGFR3 in two-compartment premalignant prostate tumors.
Jin C; Wang F; Wu X; Yu C; Luo Y; McKeehan WL
Cancer Res; 2004 Jul; 64(13):4555-62. PubMed ID: 15231666
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneous resistance mechanisms in an EGFR exon 19-mutated non-small cell lung cancer patient treated with erlotinib: Persistent FGFR3-mutation, localized transformation to EGFR-mutated SCLC, and acquired T790M EGFR-mutation.
Santoni-Rugiu E; Grauslund M; Melchior LC; Costa JC; Sørensen JB; Urbanska EM
Lung Cancer; 2017 Nov; 113():14-17. PubMed ID: 29110841
[TBL] [Abstract][Full Text] [Related]
16. Sequential exposure to fibroblast growth factors (FGF) 2, 9 and 18 enhances hMSC chondrogenic differentiation.
Correa D; Somoza RA; Lin P; Greenberg S; Rom E; Duesler L; Welter JF; Yayon A; Caplan AI
Osteoarthritis Cartilage; 2015 Mar; 23(3):443-53. PubMed ID: 25464167
[TBL] [Abstract][Full Text] [Related]
17. Effect of diadenosine polyphosphates in achondroplasic chondrocytes: inhibitory effect of Ap4A on FGF9 induced MAPK cascade.
Guzmán-Aránguez A; Irazu M; Yayon A; Pintor J
Biochem Pharmacol; 2007 Aug; 74(3):448-56. PubMed ID: 17543287
[TBL] [Abstract][Full Text] [Related]
18. Interaction of FGF9 with FGFR3-IIIb/IIIc, a putative driver of growth and aggressive behaviour of hepatocellular carcinoma.
Paur J; Valler M; Sienel R; Taxauer K; Holzmann K; Marian B; Unterberger A; Mohr T; Berger W; Gvozdenovich A; Schimming J; Grusch M; Grasl-Kraupp B
Liver Int; 2020 Sep; 40(9):2279-2290. PubMed ID: 32378800
[TBL] [Abstract][Full Text] [Related]
19. Expression and possible function of fibroblast growth factor 9 (FGF9) and its cognate receptors FGFR2 and FGFR3 in postnatal and adult retina.
Cinaroglu A; Ozmen Y; Ozdemir A; Ozcan F; Ergorul C; Cayirlioglu P; Hicks D; Bugra K
J Neurosci Res; 2005 Feb; 79(3):329-39. PubMed ID: 15614790
[TBL] [Abstract][Full Text] [Related]
20. The correlation between adiponectin and FGF9 in depression disorder.
Wang XQ; Li WH; Tang YH; Wu LF; Zeng GR; Wang YH; Cheng ZN; Jiang DJ
Brain Res; 2020 Feb; 1729():146596. PubMed ID: 31836511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
